ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Selecting Drug Delivery Systems For Higher Doses, Viscosities And Lower Risk

  Discover how companies can de-risk their device selection as they bring this new generation of high-volume, high-viscosity biologics to market.

• Closing The Duration Gap In FDA-Approved Long-Acting Contraceptives

  A gap exists between three months and three years in FDA-approved long-acting contraceptives (LACs). A microsphere formulation enables sustained release over a six to twelve-month period.

• A Smarter Strategy For Optimizing Oncology Drug Products

  John McDermott, VP of Scientific Consulting, shares insights on the benefits of evaluating targeted oncology molecules in healthy volunteers and applying an effective platform to accelerate drug product optimization.

• Trends In Combination Products

  As demand grows for more patient-centric drug delivery via self-administration, combination products are on the rise. Explore three major regulatory themes to consider when producing drug/device combination products.

• Key Offerings To Support Your OSD On Its Journey To Market

  Examine several important factors needed to effectively support oral solid dosage therapeutic manufacturing and overcome the complexities involved.

• Containment Solutions To Help Emerging Biologic Companies

  Set up your small company for long-term success using packaging containment offerings and services to help mitigate risks and speed up your time to market.

• Why Connect An Auto-Injector To A Smartphone?

  Why would a person with diabetes want to link their auto-injector to the Internet? Given that smartphones are so central to our everyday lives, it could be argued that the better question is: Why not? 

• Building Sustainability Into Medical Devices

  Medical device waste is a growing problem in the pharmaceutical industry. Learn how to navigate the balance between sustainability and factors like performance, safety, and regulatory compliance.

• Making The Right Choice For Multiparticulate Modified Release Dosage Forms

  Wurster processing is a versatile pharmaceutical development and manufacturing technique for multiparticulates in modified release dosage forms. Understand if it's the right method for your modified-release project.

• Delivering The Promise Of Gene Therapy

  Gene therapies rely on efficient, precise methods of delivering genetic material. Examine how combining polymeric nanoparticles with CRISPR therapies is increasing the potential for improved treatment.